nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadyl Acetate—Tamoxifen—breast cancer	0.585	1	CrCtD
Methadyl Acetate—Tamoxifen—Toremifene—breast cancer	0.0345	0.0838	CrCrCtD
Methadyl Acetate—Loperamide—Toremifene—breast cancer	0.0334	0.0811	CrCrCtD
Methadyl Acetate—Doxylamine—Toremifene—breast cancer	0.0288	0.0701	CrCrCtD
Methadyl Acetate—Phenoxybenzamine—Toremifene—breast cancer	0.0274	0.0666	CrCrCtD
Methadyl Acetate—Dextropropoxyphene—Toremifene—breast cancer	0.0274	0.0666	CrCrCtD
Methadyl Acetate—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0209	0.0509	CrCrCtD
Methadyl Acetate—Loperamide—Tamoxifen—breast cancer	0.0209	0.0509	CrCrCtD
Methadyl Acetate—Clofedanol—Toremifene—breast cancer	0.0198	0.0481	CrCrCtD
Methadyl Acetate—Benzphetamine—Toremifene—breast cancer	0.0192	0.0466	CrCrCtD
Methadyl Acetate—Orphenadrine—Toremifene—breast cancer	0.0192	0.0466	CrCrCtD
Methadyl Acetate—Doxylamine—Tamoxifen—breast cancer	0.0181	0.044	CrCrCtD
Methadyl Acetate—Benzyl Benzoate—Toremifene—breast cancer	0.0177	0.0432	CrCrCtD
Methadyl Acetate—Phenoxybenzamine—Tamoxifen—breast cancer	0.0172	0.0418	CrCrCtD
Methadyl Acetate—Dextropropoxyphene—Tamoxifen—breast cancer	0.0172	0.0418	CrCrCtD
Methadyl Acetate—Diphenhydramine—Toremifene—breast cancer	0.017	0.0414	CrCrCtD
Methadyl Acetate—Methadone—Tamoxifen—breast cancer	0.0144	0.035	CrCrCtD
Methadyl Acetate—Clofedanol—Tamoxifen—breast cancer	0.0124	0.0302	CrCrCtD
Methadyl Acetate—Orphenadrine—Tamoxifen—breast cancer	0.012	0.0292	CrCrCtD
Methadyl Acetate—Benzphetamine—Tamoxifen—breast cancer	0.012	0.0292	CrCrCtD
Methadyl Acetate—Benzyl Benzoate—Tamoxifen—breast cancer	0.0111	0.0271	CrCrCtD
Methadyl Acetate—Diphenhydramine—Tamoxifen—breast cancer	0.0107	0.026	CrCrCtD
Methadyl Acetate—Tamoxifen—ESRRA—breast cancer	0.000422	0.195	CrCbGaD
Methadyl Acetate—Tamoxifen—SULT1A1—breast cancer	0.00032	0.148	CrCbGaD
Methadyl Acetate—Orphenadrine—SCN10A—breast cancer	0.000104	0.0483	CrCbGaD
Methadyl Acetate—Levomethadyl Acetate—CYP19A1—breast cancer	0.000102	0.0472	CrCbGaD
Methadyl Acetate—Tamoxifen—ESR2—breast cancer	8.99e-05	0.0416	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP1B1—breast cancer	8.2e-05	0.038	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP19A1—breast cancer	6.02e-05	0.0279	CrCbGaD
Methadyl Acetate—Methadone—CYP19A1—breast cancer	5.97e-05	0.0276	CrCbGaD
Methadyl Acetate—Disopyramide—CYP3A4—breast cancer	5.87e-05	0.0272	CrCbGaD
Methadyl Acetate—Tamoxifen—ABCG2—breast cancer	5.66e-05	0.0262	CrCbGaD
Methadyl Acetate—Tamoxifen—ESR1—breast cancer	5.54e-05	0.0257	CrCbGaD
Methadyl Acetate—Diphenhydramine—PTGS1—breast cancer	4.97e-05	0.023	CrCbGaD
Methadyl Acetate—Dextropropoxyphene—CYP2D6—breast cancer	4.82e-05	0.0223	CrCbGaD
Methadyl Acetate—Levomethadyl Acetate—CYP3A4—breast cancer	4.78e-05	0.0221	CrCbGaD
Methadyl Acetate—Loperamide—CYP2D6—breast cancer	4.59e-05	0.0213	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP1A1—breast cancer	4.43e-05	0.0205	CrCbGaD
Methadyl Acetate—Modafinil—CYP3A4—breast cancer	4.18e-05	0.0194	CrCbGaD
Methadyl Acetate—Dextropropoxyphene—CYP3A4—breast cancer	4.13e-05	0.0191	CrCbGaD
Methadyl Acetate—Loperamide—CYP3A4—breast cancer	3.94e-05	0.0182	CrCbGaD
Methadyl Acetate—Benzphetamine—CYP3A4—breast cancer	3.62e-05	0.0168	CrCbGaD
Methadyl Acetate—Phenoxybenzamine—CYP3A4—breast cancer	3.46e-05	0.016	CrCbGaD
Methadyl Acetate—Diphenhydramine—CYP2D6—breast cancer	3.39e-05	0.0157	CrCbGaD
Methadyl Acetate—Promethazine—CYP2D6—breast cancer	3.32e-05	0.0154	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP2D6—breast cancer	3.3e-05	0.0153	CrCbGaD
Methadyl Acetate—Loperamide—ABCB1—breast cancer	3.28e-05	0.0152	CrCbGaD
Methadyl Acetate—Methadone—CYP2D6—breast cancer	3.27e-05	0.0151	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP3A4—breast cancer	2.83e-05	0.0131	CrCbGaD
Methadyl Acetate—Methadone—CYP3A4—breast cancer	2.8e-05	0.013	CrCbGaD
Methadyl Acetate—Orphenadrine—CYP3A4—breast cancer	2.75e-05	0.0127	CrCbGaD
Methadyl Acetate—Promethazine—ABCB1—breast cancer	2.37e-05	0.011	CrCbGaD
Methadyl Acetate—Tamoxifen—ABCB1—breast cancer	2.35e-05	0.0109	CrCbGaD
Methadyl Acetate—Methadone—ABCB1—breast cancer	2.33e-05	0.0108	CrCbGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL12—breast cancer	7.52e-06	0.00534	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCR4—breast cancer	7.52e-06	0.00534	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—RAF1—breast cancer	7.16e-06	0.00509	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—RELA—breast cancer	7.13e-06	0.00506	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—breast cancer	7.04e-06	0.005	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—breast cancer	7.04e-06	0.005	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL20—breast cancer	6.99e-06	0.00497	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—breast cancer	6.98e-06	0.00496	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CD4—breast cancer	6.98e-06	0.00496	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GPER1—breast cancer	6.88e-06	0.00489	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—LPAR1—breast cancer	6.77e-06	0.00481	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRB—breast cancer	6.74e-06	0.00479	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STARD8—breast cancer	6.73e-06	0.00478	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—NMBR—breast cancer	6.59e-06	0.00468	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—breast cancer	6.45e-06	0.00458	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—breast cancer	6.32e-06	0.00449	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—JUN—breast cancer	6.25e-06	0.00444	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GPER1—breast cancer	6.25e-06	0.00444	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CNR2—breast cancer	6.23e-06	0.00443	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PTGER1—breast cancer	6.13e-06	0.00435	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NMBR—breast cancer	5.99e-06	0.00425	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	5.98e-06	0.00425	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	5.98e-06	0.00425	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK8—breast cancer	5.91e-06	0.0042	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—WNT1—breast cancer	5.86e-06	0.00416	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—PIK3CA—breast cancer	5.74e-06	0.00408	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PTGER1—breast cancer	5.57e-06	0.00395	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL3—breast cancer	5.46e-06	0.00388	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCL27—breast cancer	5.46e-06	0.00388	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDE2A—breast cancer	5.46e-06	0.00388	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—breast cancer	5.41e-06	0.00384	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL2—breast cancer	5.36e-06	0.00381	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AGTR2—breast cancer	5.36e-06	0.00381	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—PTHLH—breast cancer	5.3e-06	0.00376	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK3—breast cancer	5.16e-06	0.00367	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—EDNRB—breast cancer	5.13e-06	0.00364	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—WNT10B—breast cancer	5.09e-06	0.00362	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—TGFB1—breast cancer	5.01e-06	0.00356	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL27—breast cancer	4.96e-06	0.00352	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL3—breast cancer	4.96e-06	0.00352	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDE2A—breast cancer	4.96e-06	0.00352	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—AKT1—breast cancer	4.69e-06	0.00333	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CALCA—breast cancer	4.66e-06	0.00331	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCR4—breast cancer	4.56e-06	0.00324	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL12—breast cancer	4.56e-06	0.00324	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AGTR1—breast cancer	4.12e-06	0.00293	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—RGS2—breast cancer	4e-06	0.00284	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCL20—breast cancer	3.95e-06	0.00281	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—HRAS—breast cancer	3.94e-06	0.0028	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LGR6—breast cancer	3.87e-06	0.00275	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCDC88C—breast cancer	3.87e-06	0.00275	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—LPAR1—breast cancer	3.83e-06	0.00272	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—breast cancer	3.77e-06	0.00268	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL8—breast cancer	3.7e-06	0.00263	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GPER1—breast cancer	3.69e-06	0.00262	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SFRP1—breast cancer	3.69e-06	0.00262	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RGS2—breast cancer	3.63e-06	0.00258	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDE4D—breast cancer	3.61e-06	0.00257	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL20—breast cancer	3.59e-06	0.00255	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NMBR—breast cancer	3.54e-06	0.00251	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CNR2—breast cancer	3.52e-06	0.0025	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—AKT1—breast cancer	3.48e-06	0.00247	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—LPAR1—breast cancer	3.47e-06	0.00247	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CUL5—breast cancer	3.29e-06	0.00234	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTGER1—breast cancer	3.29e-06	0.00234	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HEYL—breast cancer	3.29e-06	0.00234	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDE4D—breast cancer	3.28e-06	0.00233	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CNR2—breast cancer	3.2e-06	0.00227	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL8—breast cancer	3.12e-06	0.00221	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RSPO3—breast cancer	3.09e-06	0.0022	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AGTR2—breast cancer	3.03e-06	0.00215	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL2—breast cancer	3.03e-06	0.00215	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—WNT10B—breast cancer	3.01e-06	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—WWOX—breast cancer	3.01e-06	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—WNT1—breast cancer	3.01e-06	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PTHLH—breast cancer	2.99e-06	0.00213	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL3—breast cancer	2.93e-06	0.00208	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—INHBB—breast cancer	2.93e-06	0.00208	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL27—breast cancer	2.93e-06	0.00208	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDE2A—breast cancer	2.93e-06	0.00208	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—EDNRB—breast cancer	2.9e-06	0.00206	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DLL4—breast cancer	2.8e-06	0.00199	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BMPR2—breast cancer	2.8e-06	0.00199	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL2—breast cancer	2.75e-06	0.00195	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AGTR2—breast cancer	2.75e-06	0.00195	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PTHLH—breast cancer	2.72e-06	0.00193	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDH5—breast cancer	2.68e-06	0.0019	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CALCA—breast cancer	2.64e-06	0.00187	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—EDNRB—breast cancer	2.63e-06	0.00187	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SFRP2—breast cancer	2.63e-06	0.00187	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRLR—breast cancer	2.58e-06	0.00183	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCR4—breast cancer	2.57e-06	0.00183	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL12—breast cancer	2.57e-06	0.00183	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GLI2—breast cancer	2.49e-06	0.00177	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VCP—breast cancer	2.49e-06	0.00177	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	2.48e-06	0.00176	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LEPR—breast cancer	2.45e-06	0.00174	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CALCA—breast cancer	2.39e-06	0.0017	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL12—breast cancer	2.34e-06	0.00166	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCR4—breast cancer	2.34e-06	0.00166	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AGTR1—breast cancer	2.33e-06	0.00165	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ARHGDIA—breast cancer	2.28e-06	0.00162	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FST—breast cancer	2.22e-06	0.00158	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HEY2—breast cancer	2.19e-06	0.00156	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RPS6KB2—breast cancer	2.17e-06	0.00154	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RGS2—breast cancer	2.14e-06	0.00152	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL20—breast cancer	2.12e-06	0.00151	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AGTR1—breast cancer	2.11e-06	0.0015	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ITPR1—breast cancer	2.09e-06	0.00148	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LPAR1—breast cancer	2.05e-06	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TLE3—breast cancer	2.05e-06	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HEY1—breast cancer	2.03e-06	0.00144	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DLL1—breast cancer	1.99e-06	0.00142	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HIST1H2BC—breast cancer	1.96e-06	0.00139	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HIST1H2BK—breast cancer	1.96e-06	0.00139	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRB7—breast cancer	1.94e-06	0.00138	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDE4D—breast cancer	1.94e-06	0.00138	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CSF2—breast cancer	1.93e-06	0.00137	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TAB2—breast cancer	1.9e-06	0.00135	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ITPR1—breast cancer	1.9e-06	0.00135	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CNR2—breast cancer	1.89e-06	0.00134	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL8—breast cancer	1.89e-06	0.00134	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MMP3—breast cancer	1.88e-06	0.00134	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DKK1—breast cancer	1.84e-06	0.00131	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VEGFC—breast cancer	1.83e-06	0.0013	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JAG2—breast cancer	1.8e-06	0.00128	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—WNT1—breast cancer	1.78e-06	0.00126	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PLA2G4A—breast cancer	1.77e-06	0.00126	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CSF2—breast cancer	1.75e-06	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOTCH4—breast cancer	1.68e-06	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GZMB—breast cancer	1.67e-06	0.00119	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL2—breast cancer	1.62e-06	0.00115	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AGTR2—breast cancer	1.62e-06	0.00115	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BMP2—breast cancer	1.61e-06	0.00114	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTHLH—breast cancer	1.61e-06	0.00114	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EDNRB—breast cancer	1.56e-06	0.0011	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PGR—breast cancer	1.54e-06	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—THBS1—breast cancer	1.53e-06	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FLT1—breast cancer	1.46e-06	0.00104	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SQSTM1—breast cancer	1.46e-06	0.00103	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF3—breast cancer	1.46e-06	0.00103	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CG—breast cancer	1.45e-06	0.00103	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JAG1—breast cancer	1.44e-06	0.00102	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PARP1—breast cancer	1.43e-06	0.00102	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOTCH3—breast cancer	1.43e-06	0.00102	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CALCA—breast cancer	1.41e-06	0.001	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RPS6—breast cancer	1.4e-06	0.000992	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF4—breast cancer	1.39e-06	0.000985	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL12—breast cancer	1.38e-06	0.000981	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCR4—breast cancer	1.38e-06	0.000981	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PAK1—breast cancer	1.36e-06	0.000963	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TCF7L2—breast cancer	1.33e-06	0.000946	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT2—breast cancer	1.33e-06	0.000942	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CG—breast cancer	1.32e-06	0.000935	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HSP90AA1—breast cancer	1.28e-06	0.000912	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOTCH2—breast cancer	1.28e-06	0.000912	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CD—breast cancer	1.27e-06	0.000905	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AGTR1—breast cancer	1.25e-06	0.000887	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRL—breast cancer	1.25e-06	0.000887	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADAM10—breast cancer	1.23e-06	0.000874	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STK11—breast cancer	1.23e-06	0.000874	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLG—breast cancer	1.22e-06	0.000865	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT2—breast cancer	1.2e-06	0.000855	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF10—breast cancer	1.2e-06	0.000851	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CD—breast cancer	1.16e-06	0.000822	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDGFA—breast cancer	1.16e-06	0.000821	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TGFBR2—breast cancer	1.14e-06	0.000809	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ITPR1—breast cancer	1.12e-06	0.000796	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ERBB4—breast cancer	1.11e-06	0.000791	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STAT5A—breast cancer	1.11e-06	0.000791	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MMP3—breast cancer	1.11e-06	0.000791	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CB—breast cancer	1.11e-06	0.000789	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SMAD4—breast cancer	1.08e-06	0.000766	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IGF1R—breast cancer	1.07e-06	0.000761	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL8—breast cancer	1.07e-06	0.000758	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HES1—breast cancer	1.05e-06	0.000748	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLA2G4A—breast cancer	1.05e-06	0.000743	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NCOR1—breast cancer	1.05e-06	0.000743	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CSF2—breast cancer	1.04e-06	0.000735	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF1—breast cancer	1.04e-06	0.000735	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RAF1—breast cancer	1.03e-06	0.000733	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NRG1—breast cancer	1.03e-06	0.00073	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—H2AFX—breast cancer	1.02e-06	0.000725	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL2—breast cancer	1.02e-06	0.000724	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—E2F1—breast cancer	1.01e-06	0.000719	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	1.01e-06	0.000716	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SPP1—breast cancer	9.73e-07	0.000691	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL8—breast cancer	9.69e-07	0.000688	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ERBB3—breast cancer	9.63e-07	0.000684	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGFR2—breast cancer	9.61e-07	0.000683	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL2—breast cancer	9.26e-07	0.000658	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TERT—breast cancer	9.23e-07	0.000655	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGFR1—breast cancer	8.96e-07	0.000636	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HIF1A—breast cancer	8.82e-07	0.000627	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LEP—breast cancer	8.61e-07	0.000612	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CAV1—breast cancer	8.53e-07	0.000606	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—KDR—breast cancer	8.44e-07	0.000599	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ESR1—breast cancer	8.22e-07	0.000584	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FN1—breast cancer	8.12e-07	0.000577	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NFKBIA—breast cancer	8.03e-07	0.00057	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOTCH1—breast cancer	7.95e-07	0.000565	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—KIT—breast cancer	7.77e-07	0.000552	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APC—breast cancer	7.77e-07	0.000552	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CG—breast cancer	7.77e-07	0.000552	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EGF—breast cancer	7.68e-07	0.000546	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MAPK3—breast cancer	7.44e-07	0.000529	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BRAF—breast cancer	7.31e-07	0.000519	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IGF1—breast cancer	7.12e-07	0.000505	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT2—breast cancer	7.11e-07	0.000505	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—EGFR—breast cancer	7.08e-07	0.000503	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CD—breast cancer	6.83e-07	0.000485	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	6.77e-07	0.000481	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SERPINE1—breast cancer	6.76e-07	0.00048	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—KRAS—breast cancer	6.69e-07	0.000475	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOS3—breast cancer	6.45e-07	0.000458	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	6.15e-07	0.000437	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MDM2—breast cancer	6.12e-07	0.000435	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RAF1—breast cancer	6.1e-07	0.000433	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RELA—breast cancer	6.07e-07	0.000431	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ERBB2—breast cancer	6.04e-07	0.000429	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CB—breast cancer	5.96e-07	0.000423	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MTOR—breast cancer	5.96e-07	0.000423	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL8—breast cancer	5.72e-07	0.000407	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HRAS—breast cancer	5.69e-07	0.000404	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDKN1B—breast cancer	5.59e-07	0.000397	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—breast cancer	5.53e-07	0.000393	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CASP3—breast cancer	5.48e-07	0.000389	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL2—breast cancer	5.47e-07	0.000388	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6—breast cancer	5.44e-07	0.000387	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCND1—breast cancer	5.33e-07	0.000379	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JUN—breast cancer	5.32e-07	0.000378	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CTNNB1—breast cancer	5.28e-07	0.000375	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MMP9—breast cancer	5.18e-07	0.000368	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDKN1A—breast cancer	5.16e-07	0.000366	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTEN—breast cancer	5.15e-07	0.000366	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAPK8—breast cancer	5.03e-07	0.000358	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT1—breast cancer	5.02e-07	0.000357	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SRC—breast cancer	4.77e-07	0.000339	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VEGFA—breast cancer	4.65e-07	0.00033	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STAT3—breast cancer	4.6e-07	0.000327	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAPK3—breast cancer	4.4e-07	0.000312	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MYC—breast cancer	4.28e-07	0.000304	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TGFB1—breast cancer	4.27e-07	0.000303	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EGFR—breast cancer	4.18e-07	0.000297	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—KRAS—breast cancer	3.95e-07	0.000281	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CA—breast cancer	3.63e-07	0.000258	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TP53—breast cancer	3.51e-07	0.000249	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HRAS—breast cancer	3.36e-07	0.000239	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6—breast cancer	3.21e-07	0.000228	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT1—breast cancer	2.97e-07	0.000211	CbGpPWpGaD
